Clients

Arch Therapeutics, Inc.

Company Snapshot: Arch Therapeutics, Inc.

ARTH
Last Change Volume High Low

Company Overview

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Client News

  1. Mar 23 2020 Arch Therapeutics Receives Marketing Clearance from the US FDA Related to the AC5® Topical Gel Supply Chain
  2. Mar 18 2020 Arch Therapeutics, Inc. to Present at the New York City based Investor Summit on March 25th-26th
  3. Mar 4 2020 Arch Therapeutics Novel Self-Assembling Agent for Use in Endoscopic Procedures to be Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting on April 2, 2020
  4. Mar 2 2020 Arch Therapeutics to Provide Corporate Update at the 2020 LD Micro Virtual Investor Conference
  5. Jan 8 2020 Arch Therapeutics to Provide Corporate Update at Biotech Showcase™ 2020 on January 13th, 2020